Pulmonx (LUNG) Change in Receivables (2019 - 2025)

Pulmonx (LUNG) has 7 years of Change in Receivables data on file, last reported at -$1.4 million in Q3 2025.

• On a quarterly basis, Change in Receivables fell 492.76% year-over-year to -$1.4 million in Q3 2025; TTM through Sep 2025 was $2.3 million, a 70.96% increase from a year earlier, with the FY2024 full-year figure at $1.3 million, down 57.86% from the prior year.
• Change in Receivables for Q3 2025 stood at -$1.4 million, down from $1.2 million in the prior quarter.
• Over the last five years, Change in Receivables for LUNG reached as high as $1.8 million in Q4 2023 and fell as low as -$1.4 million in Q3 2025.
• Historically, Change in Receivables has averaged $503421.1 across 5 years, with a median of $715000.0 in 2023.
• Across the five-year window, Change in Receivables surged 793.41% in 2023 and plunged 492.76% in 2025, its largest moves.
• Year by year, Change in Receivables stood at -$387000.0 in 2021, then jumped by 431.78% to $1.3 million in 2022, then surged by 37.23% to $1.8 million in 2023, then decreased by 1.19% to $1.7 million in 2024, then tumbled by 180.99% to -$1.4 million in 2025.
• Per Business Quant data, the three most recent Change in Receivables figures were -$1.4 million in Q3 2025, $1.2 million in Q2 2025, and $721000.0 in Q1 2025.